Yu Galaxy is a High Impact Venture Capital Firm in Silicon Valley

We partner with entrepreneurs to develop products, services and technologies that impact billions of lives across the universe.

Meet Our Stars

Who We Are

By investing in a wide range of sectors we help great teams create category-defining companies in a vast array of industries. We prefer to lead a startup’s early fundraising round, or participate as a major investor. We don’t just pick winners; we help make them.

Learn More

Who We Have Partnered With

Revolutionary radiotherapy that treats patients in upright positions.

AI tools that can predict incidents and reduce downtime for IT systems.

Wireless charging and fleet management for robots and drones.

See More Stars

What We Have Been Up To

Capstan Medical Secures $110M to Bring First-of-its-Kind Robotics Technology to Heart Disease Patients

Led by Eclipse, the round will further allow the company to bring the benefits of robotics to one of the few remaining untouched areas of medicine and structural heart

Inquis Medical Announces $40 Million Series B Financing to Accelerate Advancement of Aventus Thrombectomy System Addressing Venus Thromboembolic Diseases

MENLO PARK, Calif.--(BUSINESS WIRE)--Inquis Medical, a pioneering medical technology company specializing in advanced thrombectomy systems, today announced the successful closure of its $40 million Series B financing round.

Be bolder: What leaders can learn from CU Boulder’s successes in research, innovation, and football

Recognize that it’s never too late to rebuild and revive your organization. If a public university of almost 150 years of history could do it, why can’t yours?

Wibotic Releases High-Power 1kW Wireless Charging System

The company's new, high-power 1kW system can operate from any 110V 15A circuit or greater, expanding the potential reach of contactless charging in higher-power applications.

Concha Labs' Waitlist is Open!

Concha Labs will be launching its new OTC hearing aid for use with its app personalization app later this year and the waitlist is now open for those interested in being the first to try it out.

Transforming Medicine: Aqtual Secures $16M Series A to Pioneer Precision Treatment Solutions Copy

Aqtual secures $16M Series A to revolutionize precision medicine, offering hope for personalized treatments in diseases like rheumatoid arthritis and cancer.

See More News